UnitedHealth Group (XSWX:UNH) YoY EBITDA Growth: 43.01% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:UNH UnitedHealth Group Inc XSWX:UNH
78 GF Score
Price CHF310.35
GF Value CHF477.98
! 6 Warning Signs
View Full Analysis

What is UnitedHealth Group YoY EBITDA Growth?

UnitedHealth Group XSWX:UNH -1.15% 78 YoY EBITDA Growth is 43.01% as of Jun. 2026. GuruFocus rates XSWX:UNH with a GF Score™ of 78/100 and a GF Value™ of CHF477.98. The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. UnitedHealth Group's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 43.01%.

UnitedHealth Group's EBITDA per Share for the three months ended in Jun. 2026 was CHF7.91.

UnitedHealth Group YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for UnitedHealth Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UnitedHealth Group YoY EBITDA Growth Chart

UnitedHealth Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.53 19.69 7.29 -19.55 -25.14

UnitedHealth Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.08 -47.26 -85.86 -12.04 43.01
XSWX:UNH
78GF Score
UnitedHealth Group Inc XSWX:UNH
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UnitedHealth Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

UnitedHealth Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(20.172-26.946)/ | 26.946 |
=-25.14 %

UnitedHealth Group's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(7.914-5.534)/ | 5.534 |
=43.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 43.01% mean?
UnitedHealth Group (XSWX:UNH) has a YoY EBITDA Growth of 43.01% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for UnitedHealth Group and its competitors.
Is UnitedHealth Group's YoY EBITDA Growth too high?
UnitedHealth Group's current YoY EBITDA Growth is 43.01%. Overall, UnitedHealth Group has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does UnitedHealth Group's YoY EBITDA Growth compare to CVS and ELV?
UnitedHealth Group's YoY EBITDA Growth of 43.01% can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Plans company?
A good YoY EBITDA Growth depends on the Healthcare Plans industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for UnitedHealth Group and its competitors. UnitedHealth Group's current YoY EBITDA Growth is 43.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnitedHealth Group stock overvalued right now?
UnitedHealth Group (XSWX:UNH) has a current YoY EBITDA Growth of 43.01%. The stock's GF Value™ is CHF477.98, compared to a current price of CHF310.35 — trading 35.1% below its estimated fair value. The current YoY EBITDA Growth is 43.01%. UnitedHealth Group's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For UnitedHealth Group (XSWX:UNH), the current YoY EBITDA Growth is 43.01% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UnitedHealth Group (XSWX:UNH) Overvalued in 2026?

Based on GuruFocus' analysis, UnitedHealth Group stock appears to be undervalued. The current stock price of CHF310.35 is trading 35.1% below its estimated GF Value™ of CHF477.98.

Key valuation signals for XSWX:UNH:

  • YoY EBITDA Growth: 43.01%
  • GF Value™: CHF477.98 vs. price of CHF310.35 (35.1% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the XSWX:UNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

UnitedHealth Group Business Description

Address 1 Health Drive, Eden Prairie, MN, USA, 55344
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
78GF Score

Get the complete analysis for XSWX:UNH

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF310.35
Price
CHF477.98
GF Value